Form 483

US Specialty Formulations LLC Form 483, 2026-01-14

FDA issued a Form 483 to US Specialty Formulations LLC on 2026-01-14 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

US Specialty Formulations LLC · Allentown, United States · Issued January 14, 2026

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Jan 2026
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.165(e)

Test methods

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.166(a)

Lack of written stability program

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Mindy M Chou, Lu Chen

Inspected site

USUS Specialty Formulations LLCAllentown, United States

Inspection team

LCLu Chen

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(3)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere